Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 14/12/2017
SIETES contiene 92152 citas

 
 
 1 a 20 de 341 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Patel P, Leeder JS, Piquette-Miller M, Dupuis LL. Aprepitant and fosaprepitant drug interactions: a systematic review. Br J Clin Pharmacol 2017;83:2148-62. [Ref.ID 102081]
2. Cita con resumen
Ebell MH. WHO downgrades status of oseltamivir. BMJ 2017;358:j3266. [Ref.ID 101981]
3. Cita con resumen
Bradford AC, Bradford WD. Medical marijuana laws may be associated with a decline in the number of prescriptions for Medicaid enrollees. Health Affairs 2017;36:1 de mayo. [Ref.ID 101570]
4.Enlace a cita original Cita con resumen
DREAMS Trial Collaborators and West Midlands Research Collaborative. Dexamethasone versus standard treatment for postoperative nausea and vomiting in gastrointestinal surgery: randomised controlled trial (DREAMS Trial). BMJ 2017;357:j1455. [Ref.ID 101540]
5. Cita con resumen
Anónimo. Aprépitant chez les enfants. Prescrire 2017;37:5-7. [Ref.ID 101361]
6. Cita con resumen
Anónimo. FDA approves drug for pregnancy-related nausea and vomiting. DIA Daily 2016:2. [Ref.ID 100938]
7. Cita con resumen
Navari RM, Qin R, Ruddy KJ, Liu H, Powell SF, Bajaj M, Dietrich L, Lafky JM, Loprinzi CL. Olanzapine for the prevention of chemotherapy-induced nausea and vomiting. N Engl J Med 2016;375:134-42. [Ref.ID 100630]
8. Cita con resumen
Anónimo. Cannabis and cannabinoids. Med Lett Drugs Ther 2016;58:97-8. [Ref.ID 100510]
9. Cita con resumen
Anónimo. FDA approves first dronabinol solution for oral use. FDA U.S. Food and Drug Administration 2016:2. [Ref.ID 100472]
10. Cita con resumen
Carstairs S. Ondansetron use in pregnancy and birth defects: A systematic review. Obstet Gynecol 2016;127:878-83. [Ref.ID 100204]
11. Cita con resumen
Voelker R. New pancreatic cancer drug. JAMA 2015;314:2227. [Ref.ID 99728]
12. Cita con resumen
Voelker R. New atypical antipsychotic. JAMA 2015;314:1789. [Ref.ID 99676]
13. Cita con resumen
Anónimo. FDA approves new drug to treat schizophrenia and bipolar disorder. FDA U.S. Food and Drug Administration 2015:17 de septiembre. [Ref.ID 99502]
14. Cita con resumen
Anónimo. Netupitant/palonosetron (Akynzeo) for chemotherapy-induced nausea. Med Lett Drugs Ther 2015;57:61-3. [Ref.ID 99448]
15. Cita con resumen
Anónimo. FDA approves new drug treatment for nausea and vomiting from chemotherapy. FDA U.S. Food and Drug Administration 2015:2 de septiembre. [Ref.ID 99434]
17.Tiene citas relacionadas Cita con resumen
Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, Keurentjes JC, Lang S, Misso K, Ryder S D, Schmidikofer S, Westwood M, Kleijnen J. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 2015;313:2456-73. [Ref.ID 99308]
18. Cita con resumen
Anónimo. Drugs for the doctor's bag: 2-children. Drug Ther Bull 2015;53:69-72. [Ref.ID 99214]
19. Cita con resumen
Law R, Schier J, Martin C, Chang A, Wolkin A. Notes from the Field: Increase in Reported Adverse Health Effects Related to Synthetic Cannabinoid Use — United States, January–May 2015. MMWR Morb Mortal Wkly Rep 2015;64:618-9. [Ref.ID 99193]
Seleccionar todas
 
 1 a 20 de 341 siguiente >>